Liqun Jiao Selected Research

Ischemic Stroke

4/2024	Vascular Endothelial Growth Factor and Ischemic Stroke Risk: A Mendelian Randomization Study.
1/2024	Alterations of Hemostatic Molecular Markers During Acute Large Vessel Occlusion Stroke.
1/2024	Evolution pattern estimated by computed tomography perfusion post-thrombectomy predicts outcome in acute ischemic stroke.
9/2023	Clinical evidence comparing bridging and direct endovascular thrombectomy: progress and controversies.
8/2023	Clinical evidence in ischemic stroke: Where we have gone so far and hopes for the future.
7/2023	Impact of qualifying artery on the efficacy of stenting plus medical therapy versus medical therapy alone in patients with symptomatic intracranial stenosis: a post-hoc analysis of the CASSISS trial.
7/2023	Thrombosis origin identification of cardioembolism and large artery atherosclerosis by distinct metabolites.
5/2023	Early venous filling after mechanical thrombectomy in acute ischemic stroke due to large vessel occlusion in anterior circulation.
1/2023	Extracranial-Intracranial Bypass and Risk of Stroke and Death in Patients With Symptomatic Artery Occlusion: The CMOSS Randomized Clinical Trial.
1/2023	Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liqun Jiao Research Topics

Disease

39	Pathologic Constriction (Stenosis) 02/2024 - 01/2009
33	Ischemic Stroke 04/2024 - 01/2016
27	Stroke (Strokes) 04/2024 - 11/2014
18	Carotid Stenosis (Carotid Artery Stenosis) 01/2024 - 11/2014
8	Inflammation (Inflammations) 01/2024 - 01/2020
6	Atherosclerosis 03/2024 - 11/2022
4	Vertebrobasilar Insufficiency 07/2023 - 01/2016
4	Hypertension (High Blood Pressure) 01/2023 - 01/2009
4	Atherosclerotic Plaque (Atheroma) 01/2023 - 04/2021
4	COVID-19 10/2022 - 01/2020
3	Embolic Stroke 04/2024 - 01/2021
3	Moyamoya Disease (Moya-Moya Disease) 10/2023 - 01/2019
3	Transient Ischemic Attack 07/2023 - 04/2017
3	Infarction (Infarctions) 02/2023 - 01/2020
3	Thrombosis (Thrombus) 01/2023 - 01/2014
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 01/2022
3	Cerebral Infarction 01/2023 - 11/2020
3	Infections 01/2022 - 01/2020
3	Rupture 01/2022 - 07/2017
2	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 02/2024 - 01/2009
2	Neoplasms (Cancer) 01/2023 - 01/2022
2	Brain Ischemia (Cerebral Ischemia) 06/2022 - 05/2021
2	Blood Vessel Dissection 01/2022 - 01/2014
2	Hyperplasia 03/2021 - 01/2016
2	Diabetes Mellitus 01/2021 - 09/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2024
1	Asthma (Bronchial Asthma) 01/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2023
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 09/2023
1	Disease Progression 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Carotid Artery Diseases 01/2023
1	Cerebral Hemorrhage 10/2022
1	Thromboinflammation 10/2022
1	Diaschisis 09/2022
1	Brain Edema (Cerebral Edema) 06/2022

Drug/Important Bio-Agent (IBA)

7	LipidsIBA 01/2023 - 07/2017
3	Circular RNAIBA 01/2024 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2022
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 06/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2022
2	insulin receptor-related receptor (IRR)IBA 01/2021 - 08/2020
2	MetalsIBA 10/2020 - 01/2020
1	Vascular Endothelial Growth FactorsIBA 04/2024
1	EnzymesIBA 03/2024
1	AntioxidantsIBA 03/2024
1	Sirolimus (Rapamycin)FDA Link 02/2024
1	Plasminogen InactivatorsIBA 01/2024
1	fibrin fragment D (D-dimer)IBA 01/2024
1	antithrombin III-protease complexIBA 01/2024
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2024
1	Fibrinolysin FDA Link 01/2024
1	Hemostatics (Antihemorrhagics)IBA 01/2024
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2024
1	ThrombomodulinIBA 01/2024
1	Cytidine Triphosphate (CTP)IBA 01/2024
1	oil red OIBA 01/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	Omalizumab (Xolair)FDA Link 01/2024
1	SolutionsIBA 01/2024
1	Dynamins (Dynamin)IBA 01/2024
1	Immunoglobulin E (IgE)IBA 01/2024
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023
1	Discoidin Domain ReceptorsIBA 12/2023
1	ORALIT (ORS)IBA 07/2023
1	X-Box Binding Protein 1IBA 04/2023
1	Inositol (Myoinositol)IBA 04/2023
1	CytokinesIBA 01/2023
1	Ether (Diethyl Ether)IBA 01/2023
1	CholesterolIBA 01/2023
1	SphingolipidsIBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2023
1	PCSK9 InhibitorsIBA 11/2022
1	C-Reactive ProteinIBA 11/2022
1	Interleukin-6 (Interleukin 6)IBA 11/2022
1	Proprotein Convertase 9IBA 11/2022
1	Syndecan-1 (Syndecan 1)IBA 10/2022
1	LigandsIBA 10/2022
1	DisintegrinsIBA 10/2022
1	Metalloproteases (Metalloproteinases)IBA 10/2022
1	ThrombospondinsIBA 10/2022
1	Peptide Hydrolases (Proteases)FDA Link 10/2022
1	von Willebrand FactorIBA 10/2022

Therapy/Procedure

34	Therapeutics 02/2024 - 01/2009
25	Thrombectomy 01/2024 - 01/2018
23	Stents 09/2023 - 01/2009
15	Carotid Endarterectomy 01/2023 - 11/2014
6	Catheters 01/2022 - 11/2017
4	General Anesthesia 01/2022 - 01/2021
3	Perioperative Period 01/2023 - 01/2021
3	Drug-Eluting Stents 04/2021 - 01/2009
2	Endarterectomy (Thromboendarterectomy) 10/2022 - 08/2017
1	Neurological Rehabilitation 11/2023
1	Cerebral Revascularization 10/2023